hexylresorcinol has been researched along with Carcinoma, Anaplastic in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "4‑Hexylresorcinol (4HR) is a pharmacologic chaperone." | 1.72 | Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation. ( Chae, WS; Kang, YJ; Kim, DW; Kim, SG; Rotaru, H; Yang, WG, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, YJ | 1 |
| Yang, WG | 1 |
| Chae, WS | 1 |
| Kim, DW | 1 |
| Kim, SG | 1 |
| Rotaru, H | 1 |
| KOSHIMURA, S | 1 |
| MURASAWA, K | 1 |
| NAKAGAWA, E | 1 |
| UEDA, M | 1 |
| BANDO, Y | 1 |
| HIRATA, R | 1 |
| KOSHIURA, RH | 1 |
| KAGOTANI, Y | 1 |
| UJIIE, T | 1 |
3 other studies available for hexylresorcinol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; DNA; Hexylresorcinol; Humans; Mouth Neoplasms; Mutation; Pro | 2022 |
[Experimental anticancer studies. II. On the anti-tumor effect of 6-(2'-hydroxy-3', 5'-dihalophenylazo)-4-hexylresorcinol and related compounds on Yoshida sarcoma and Ehrlich ascites carcinoma in vivo].
Topics: Animals; Antineoplastic Agents; Ascites; Carcinoma; Hexylresorcinol; Neoplasms; Sarcoma, Yoshida | 1956 |
Experimental anticancer studies. XVI. Preparation and anticancer activity of 4-amino-6-hexylresorcinol on Ehrlich carcinoma in mice.
Topics: Animals; Antineoplastic Agents; Carcinoma; Hexylresorcinol; Mice | 1962 |